ImmunityBio Inc【IBRX】 業績推移・財務諸表

機能の使い方
(単位:千ドル) 2Q15 3Q15 4Q15 1Q16 2Q16 3Q16 4Q16 1Q17 2Q17 3Q17 4Q17 1Q18 2Q18 3Q18 4Q18 1Q19 2Q19 3Q19 4Q19 1Q20 2Q20 3Q20 4Q20 1Q21 2Q21 3Q21 4Q21 1Q22 2Q22 3Q22 4Q22 1Q23 2Q23 3Q23 4Q23 1Q24 2Q24 3Q24 4Q24 1Q25 2Q25 3Q25 4Q25
売上高 91 10 15 6 12 12 14 11 14 8 12 5 4 31 7 5 17 12 9 21 1 68 21 139 339 66 390 14 35 118 73 360 41 82 139 40 1,047 6,106 7,552 16,517 26,425 32,061 38,285
売上成長率(%) - - - - 5333.1 41192.5 2423.9 425.1 407.0
売上原価 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 58 136 177 382
研究開発費 1,745 3,950 5,106 4,944 6,389 8,364 9,445 9,248 9,706 11,069 12,021 13,991 14,688 14,559 12,480 12,598 13,131 12,052 12,004 13,234 13,709 17,284 20,256 41,128 53,800 49,277 51,753 55,378 63,082 71,612 58,077 79,264 53,168 48,402 51,532 53,351 51,129 50,443 35,221 - - - -
販売管理費 82,429 38,854 25,838 26,651 28,588 24,423 15,713 16,227 14,128 13,381 13,385 14,298 13,594 9,580 5,246 5,742 4,182 4,025 4,116 5,373 6,519 4,711 10,651 45,275 32,445 29,625 27,911 40,608 16,575 19,310 26,215 32,676 32,018 31,816 33,110 41,885 49,251 35,916 41,731 - - - -
営業費用 84,174 42,804 - 31,595 34,977 32,787 25,157 25,475 23,834 24,450 25,406 28,289 28,282 24,139 17,726 18,340 17,313 16,077 16,120 18,607 20,228 21,995 30,907 86,403 86,245 78,902 79,664 95,986 79,657 90,922 84,973 111,940 85,186 80,218 85,528 95,236 100,380 86,359 76,952 80,946 97,710 87,691 102,968
営業利益 -84,083 -42,794 - -31,589 -34,965 -32,775 -25,143 -25,464 -23,820 -24,442 -25,394 -28,284 -28,278 -24,108 -17,719 -18,335 -17,296 -16,065 -16,111 -18,586 -20,227 -21,927 -30,886 -86,264 -85,906 -78,836 -79,274 -95,972 -79,622 -90,804 -84,900 -111,580 -85,145 -80,136 -85,389 -95,196 -99,333 -80,253 -69,400 -64,429 -71,285 -55,630 -64,683
営業利益率 (%) - -919.0 -390.1 -269.8 -173.5 -169.0
経常(税引前)利益 -84,581 -42,649 - -30,793 -34,225 -31,949 -24,387 -24,613 -23,576 -24,068 -24,659 -27,643 -27,855 -23,763 -17,468 -17,921 -16,680 -15,581 -15,704 -18,383 -20,088 -21,774 -32,133 -80,475 -89,383 -88,429 -91,552 -102,998 -94,835 -111,161 -108,292 -116,583 -138,213 -95,642 -233,454 -134,130 -134,584 -85,752 -59,179 -129,900 -92,305 -67,309 -62,093
経常(税引前)利益率(%) -92946.2 -426490.0 - -513216.7 -285208.3 -266241.7 -174192.9 -223754.5 -168400 -300850 -205491.7 -552860 -696375 -76654.8 -249542.9 -358420 -98117.6 -129841.7 -174488.9 -87538.1 -2008800 -32020.6 -153014.3 -57895.7 -26366.7 -133983.3 -23474.9 -735700 -270957.1 -94204.2 -148345.2 -32384.2 -337104.9 -116636.6 -167952.5 -335325 -12854.3 -1404.4 -783.6 -786.5 -349.3 -209.9 -162.2
法人税等合計 - 0 -302 -143 -228 -52 -149 -98 -124 -99 -172 -124 -123 -128 -128 -36 2 0 -63 0 4 2 -1 6 2 0 1 - - - - - - - - - - - - -200 300 -35 -200
実効税率(%) - - - - - - - - - - - - - - 0.2 -0.3 0.1 0.3
純利益 -84,581 -42,649 -26,822 -30,650 -33,997 -31,897 -24,238 -24,515 -23,452 -23,969 -24,487 -27,519 -27,732 -23,635 -17,340 -17,885 -16,682 -15,581 -15,641 -18,383 -20,092 -21,776 -32,132 -79,614 -88,288 -87,629 -91,259 -102,826 -94,588 -110,938 -108,215 -116,343 -137,879 -95,582 -233,392 -134,109 -134,564 -85,729 -59,162 -129,646 -92,555 -67,253 -61,944
純利益率(%) -783.4 -784.9 -350.3 -209.8 -161.8
一株あたり利益 - - - - - - - - - - - - - - - - - - - - - - - - - -0.22 -0.23 -0.26 -0.24 -0.28 -0.27 -0.27 -0.32 -0.19 -0.38 -0.2 -0.2 -0.12 -0.07 -0.15 -0.1 -0.07 -0.06
希薄化後一株あたり利益 - - - - - - - - - - - - - - - - - - - - - - - - - -0.22 -0.23 -0.26 -0.24 -0.28 -0.27 -0.27 -0.32 -0.19 -0.38 -0.2 -0.2 -0.14 -0.09 -0.15 -0.1 -0.07 -0.06
EBITDA - - -65,262 -60,600 -67,405 -51,679 -60,818
EBITDAマージン(%) - - -864.2 -366.9 -255.1 -161.2 -158.9